These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2474975)

  • 21. Defective autologous mixed-lymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease.
    Ginsburg CH; Falchuk ZM
    Gastroenterology; 1982 Jul; 83(1 Pt 1):1-9. PubMed ID: 6210596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenetic models ulcerative colitis and Crohn disease].
    Feller AC; Löhler J; Reimann J; Merz H
    Verh Dtsch Ges Pathol; 1996; 80():104-8. PubMed ID: 9064992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Are Crohn disease and ulcerative colitis the results of an immunoregulatory disturbance?].
    Raedler A; Schmiegel WH; Thiele HG
    Immun Infekt; 1982 Sep; 10(5):175-9. PubMed ID: 6757110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aetiological theories of inflammatory bowel disease.
    Sachar DB; Auslander MO; Walfish JS
    Clin Gastroenterol; 1980 May; 9(2):231-57. PubMed ID: 6993058
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease.
    Korsmeyer S; Strickland RG; Wilson ID; Williams RC
    Gastroenterology; 1974 Oct; 67(4):578-83. PubMed ID: 4607065
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic studies in patients with Crohn disease and ulcerative colitis].
    Sauer H; Sauer D; Bendix U; Schumann B
    Allerg Immunol (Leipz); 1984; 30(1):23-33. PubMed ID: 6203390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immunofluorescence study of the intestinal mucosa in ulcerative colitis and Crohn's disease.
    Green FH; Fox H
    J Pathol; 1973 Jul; 110(3):Pii. PubMed ID: 4582851
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunological aspects of intestinal diseases].
    Kovács A
    Orv Hetil; 1972 Jun; 113(24):1395-8. PubMed ID: 5032302
    [No Abstract]   [Full Text] [Related]  

  • 30. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
    Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunology of inflammatory bowel disease--an update.
    Jewell DP
    J Gastroenterol; 1995 Nov; 30 Suppl 8():78-82. PubMed ID: 8563898
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
    Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
    Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: A study by immunofluorescence of the intestinal mucosa in ulcerative colitis and Crohn's disease.
    Green FH; Fox H
    J Med Microbiol; 1973 Nov; 6(4):P18. PubMed ID: 4587399
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro lymphocyte response to non-specific mitogens in inflammatory bowel disease.
    Asquith P; Kraft SC; Rothberg RM
    Gut; 1972 Apr; 13(4):320. PubMed ID: 5033849
    [No Abstract]   [Full Text] [Related]  

  • 35. [The immunology of inflammatory bowel disease (author's transl)].
    Bartnik W; Shorter RG
    Przegl Lek; 1981; 38(6):481-9. PubMed ID: 7268048
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduced serum levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in patients with inflammatory bowel disease.
    Hoffmann JC; Göke MN; Evers J; Räuker HJ; Bayer B; Manns MP
    Z Gastroenterol; 1996 Sep; 34(9):522-7. PubMed ID: 8873455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunologic aspects of digestive tract diseases].
    Radomska B
    Wiad Lek; 1972 Feb; 25(4):335-9. PubMed ID: 4551489
    [No Abstract]   [Full Text] [Related]  

  • 38. Concanavalin A induced suppressor activity exerted by peripheral blood mononuclear cells--with special reference to chronic inflammatory bowel disease.
    Davidsen BD
    Dan Med Bull; 1988 Jun; 35(3):201-22. PubMed ID: 2971513
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating immune complexes in inflammatory bowel disease.
    Jewell DP; MacLennan IC
    Clin Exp Immunol; 1973 Jun; 14(2):219-26. PubMed ID: 4197968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.
    Sartor RB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):390-407. PubMed ID: 16819502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.